Lizhi B. Chen
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
Free mycophenolic acid exposure for therapeutic drug monitoring in paediatric lupus nephritis: associations with treatment response and haematologic toxicity.
Journal: Lupus science & medicine
Published: April 10, 2026
Machine learning early risk assessment model for acute kidney injury in critically ill children: a retrospective cohort study.
Journal: Frontiers in pediatrics
Published: April 04, 2026
Comment on: Predicting mycophenolic acid exposure in pediatric lupus nephritis: a real-world study across three clinical scenarios: reply.
Journal: Rheumatology (Oxford, England)
Published: April 02, 2026
Models Integrating Disease Heterogeneity and MPA Exposure Predict Systemic and Renal Efficacy of Mycophenolate in Pediatric Lupus Nephritis.
Journal: Pharmacotherapy
Published: November 14, 2025
Optimizing mycophenolic acid exposure for reduced relapse risk in paediatric nephrotic syndrome: An observational cohort study.
Journal: British journal of clinical pharmacology
Published: August 01, 2025
Predicting mycophenolic acid exposure in paediatric lupus nephritis: a real-world study across three clinical scenarios.
Journal: Rheumatology (Oxford, England)
Published: July 01, 2025
Clinical characteristics and efficacy of intrathecal therapy in pediatric lupus encephalopathy.
Journal: Lupus
Published: May 22, 2025
Impact of body weight on mycophenolic acid population pharmacokinetics in paediatric lupus nephritis: a pharmacogenomic integration study.
Journal: Lupus science & medicine
Published: February 08, 2025
IL-17A, IL-23R, FCGR3A are associated with neuropsychiatric systemic lupus erythematosus susceptibility in pediatric patients with lupus nephritis.
Journal: Cytokine
Published: October 17, 2024
Last Updated: 09/26/2026